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Abstract
This note investigates a number of scenarios in which unadjusted
testing following a blinded sample size re-estimation leads to type I
error violations. For superiority testing, this occurs in certain small-
sample borderline cases. We discuss a number of alternative ap-
proaches that keep the type I error rate. The paper also gives a reason
why the type I error inflation in the superiority context might have
been missed in previous publications and investigates why it is more
marked in case of non-inferiority testing.
1 Introduction
Sample Size re-estimation (SSR) in clinical trials has a long history that dates
back to Stein (1945). A sample size review at an interim analysis aims at
correcting assumptions which were made at the planning stage of the trial,
but turn out to be unrealistic. When the sample units are considered to
be normally distributed, this typically concerns the initial assumption about
the variation of responses. Wittes and Brittain (1990) and Gould and Shih
(1992, 1998) among others discussed methods of blinded SSR. In contrast
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to unblinded SSR, blinded SSR assumes that the actually realized effect size
estimate is not disclosed to the decision makers who do the SSR. Wittes et
al. (1999) and Zucker et al. (1999) investigated the performance of various
blinded and unblinded SSR methods by simulation. They observed some
slight type I error violations in cases with small sample size and gave expla-
nations for this phenomenon for some of the unblinded approaches available
at that time.
Slightly later, Kieser and Friede([1], [2]) suggested a method of blinded
sample size review which is particularly easy to implement. In a trial with
normally distributed sample units with the aim of testing for a significant
treatment effect (”superiority testing”) at the final analysis, it estimates the
variance under the null hypothesis of no treatment effect and then proceeds
to an unmodified t-test in the final analysis, i.e. a test that ignores the fact
that the final sample size was not fixed from the onset of the trial. Kieser and
Friede investigated the type I error control of their suggestion by simulation.
They conclude that no additional measures to control the significance level
are required in these designs if the study is evaluated with the common t-test
and the sample size is recalculated with any of these simple blind variance
estimators.
Although Kieser and Friede explicitly stated that they provide no formal
proof of type I error control, it seems to us that many statisticians in the
pharmaceutical industry are under the impression that such a proof is avail-
able. This, however, is not the case. In this paper, we show that in certain
situations, the method suggested by Kieser and Friede does not control the
type I error.
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It should be emphasized that asymptotic type I error control with blinded
SSR is guaranteed. If the sample size of only one of the two stages tends
to infinity, the other stage is obviously irrelevant for the asymptotic value
of the final test statistic and thus the method asymptotically keeps α. If
the sample size in both stages goes to infinity, then the stage-1-estimate of
the variance converges to a constant value. Hence, whatever sample size re-
estimation rule is used, it implicitly fixes the total sample size in advance
(though its precise value is not yet known before the interim). In any case,
asymptotically α is again kept. Govindarajulu (2003) has formalized this
thought and extended to non-normally distributed data. As a consequence,
the type I error violations discussed in this note are very small and occur
in cases with small samples. We still believe, however, that the statistical
community should be made aware of these limitations of blinded sample-size
review methodology.
While sections 2-4 focus on the common case of testing for treatment
differences in clinical trials, section 5 briefly discusses the case of testing for
non-inferiority of one of the two treatments. In had been noted in another
paper by Friede and Kieser [13] that type I error inflations from SSR can be
more marked in this situation. We give an explanation of this phenomenon.
2 A scenario leading to type I error violation
In this section we show that in certain cases, a blinded sample size review as
suggested by [1] leads to a type I error which is larger than the nominal level
α.
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In general, blinded sample review is characterized by the fact that the
final sample size of the study may be changed at interim analyses, but that
this change depends on the data only via the total variance which is the
variance estimate under the null hypothesis of interest. If xi, i = 1, . . . , n1
are stochastically independent normally distributed observations, this total
variance is proportional to
∑n1
i=1 x
2
i in the one-sample and to
∑n1
i=1 x
2
i − n1x¯2
in the two-sample case.
We consider the one-sample t test of H0 : µ = 0 at level α applied to
xi ∼ N(µ, σ2). The reason for this is simplicity of notation and the fact that
the geometric considerations given below cannot be imagined for the two-
sample case which would have to deal with a dimension larger than three even
in the simplest setup. However, the restriction to the one-sample case entails
no loss of generality, as it is conceptually the same as the two sample case.
We will briefly comment on this further below. In addition, a blinded sample
size review may also be of practical relevance in the one-sample situation, for
example in cross-over trials.
Assume a blinded sample size review after n1 = 2 observations. If the
total variance is small, we stop sampling and test with the n1 = n = 2
observations we have obtained. If it is large, we take another sample element
x3, and do the test with n = 3 observations. This rule implies that n = 2
for x21 + x
2
2 ≤ r2 and n = 3 otherwise for some fixed scalar r. Geometrically,
the rejection region of the (one-sided) t test for n = 3 is a spherical cone
with the equiangular line x1 = x2 = x3 as its central axis in the three-
dimensional space. By definition, the probability mass of this cone is α
under H0. For the case of n = 2, the rejection region is a segment of the circle
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x21+x
2
2 ≤ r2 around the equiangular line x1 = x2. Hence, in three dimensions,
the rejection region is a segment of the spherical cylinder x21 + x
2
2 ≤ r2, x3
arbitrary. The probability mass covered by this segment again is α inside the
cylinder. The rejection region of the entire procedure is the segment of the
cylinder plus the spherical cone minus the intersection of the cone with the
cylinder. We now approximate the probability mass of these components.
For r2 small, we approximately have P (x21+x
2
2 ≤ r2) = r
2
2σ2
. Hence, under
H0, the probability mass of this part of the rejection region is approximately
r2
2σ2
· α. The volume of the intersection of the cone with the cylinder can
be approximated as follows: The central axis x1 = x2 = x3 of the cone
intersects with the cylinder in one of the points ±
(
r√
2
, r√
2
, r√
2
)
. The distance
of this point to the origin is thus h =
√
3
2
r. The approximate volume of the
intersection is 4pih
3
3
=
√
6pir3. To conservatively approximate the probability
mass of this intersection, we assume that every point in it has the same
probability mass as the origin (in reality, it of course has a lower probability
mass). Then the probability mass of the intersection is approximated by
√
6pir3 · α · (√2piσ)−3, where (√2piσ)−3 is the value of the standard normal
density N3 (0, σ
2I3) in the point 0. Combining these results, a conservative
approximation of the probability mass of the rejection region for the entire
procedure is
α
(
1 +
r2
2σ2
−
√
6pir3
(
√
2piσ)3
)
= α
(
1 +
r2
2σ2
−
√
3r3
2
√
piσ3
)
. (1)
Obviously, this is larger than α for small r.
For the more general case of a stage-1-sample size of n1, possibly followed
by a stage 2 with n2 further observations, the rejection region of the ”sample
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size reviewed” t test has an approximate null probability following the same
basic principle as (1):
α ·
(
1 + const1 ·
(
r√
n1σ
)n1 − const2 · ( r√n1σ
)n1+n2)
if r, n1 and n2 are small.
Consequently, there must be situations with small r√
n1σ
where the blinded
review procedure cannot keep the type I error level α exactly. Due to sym-
metry of the rejection region, this statement holds for both the one- and the
two-sided test of H0.
Note that in this example, the test keeps α exactly if
∑n1
i=1 x
2
i ≤ r2. This
is due to the sphericity of the conditional null distribution of (x1, · · · , xn1)
given
∑n1
i=1 x
2
i ≤ r2 (see [3], theorem 2.5.8). Type I error violation stems
from the fact that the test does not keep α conditional on
∑n1
i=1 x
2
i > r
2, i.e.
if a second stage of sampling more observations is done.
To investigate the magnitude of the ensuing type I error violation, we
simulated 10’000’000 cases with n1 = 2 initial observations and n2 = 2
additional observations that are only taken if x21 + x
2
2 ≥ 0.5. The true type I
error of the two-sided combined t test turned out to be 0.0542 for a nominal
α = 0.05. As expected, this is caused by the situations where stage-2-data
is obtained. Since x21 + x
2
2 ∼ χ2(2), we have P (x21 + x22 ≥ 0.5) = 0.779. This
was also the value observed in the simulations. The rejection rate for these
cases alone was 0.0553. If x21 + x
2
2 < 0.5, we know that conditionally the
rejection rate is exactly α. Accordingly, this conditional rejection rate in the
simulations was 0.0500.
If n1 and n2 are increased, the true type I error rate converges rather
quickly to α. For example, in case of n1 = n2 = 5 and r
2 = 2.5, the
simulated error rate is 0.0508 with 77.6% of cases leading to stage 2 and a
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conditional error rate of 0.0510 in case stage 2 applies.
We also performed some simulations where n2 is determined with the
algorithm suggested by [1]. For this purpose, we generated 10′000′000 simu-
lation runs of a blinded sample size review after n1 = 2 observations following
the rule given in section 3 of [1] with a very large assumed effect of δ = 2.2.
This produces an average of 3.09 additional observations n2. The simulated
type I error was 0.05077.
To see that the two-sample case is also covered by these investigations,
note that the ordinary t-test statistic can be viewed as X/
√
Y/s where
X ∼ N(δ, 1) is stochastically independent of Y ∼ χ2 (s). Regarding any
investigation of the properties of this quantity, it obviously does not matter
if the random variables X and Y arise as mean and variance estimate from
a one-sample situation or as difference in means and common within-group
variance estimate in the two-sample case. The same is true here: According
to [1], p. 3575, the ”resampled” t-test statistic consists of the four compo-
nents D1, V1, D2 |(V1, D1) and V ∗2 |(V1, D1) (loosely speaking, these corre-
spond to the differences in means and variance estimates of the two stages).
Comparing the distributions of D1 and V1 and the conditional distributions
of D2 and V
∗
2 given D1 and V1 (and hence n2), one immediately sees that
these are the same for the one- and the balanced two-sample case when we
replace ni by ni/2 and the means of the two stages by the corresponding two
differences in means between the two treatment groups. For the conditional
distribution of V ∗2 |(V1, D1) see section 4.
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3 Approaches that control the type I error
3.1 Permutation and rotation tests
If the considerations from the previous section are of concern, then a sim-
ple alternative is to do the test as a permutation test. In the one-sample
case, one would generate all permutations (or a large number of random per-
mutations) of the signs onto the absolute values of observations. For each
permutation, the t test would be calculated and the (1 − α)-quantile of the
resulting empirical distribution of t-test values gives the critical value of an
exact level α-test of H0. Alternatively, a p-value can be obtained by counting
the percentage of values from the permutation distribution which are larger
or equal to the actually observed value of the test statistic. After determin-
ing the additional sample size n2 from the first n1 observations, we apply the
permutation method to all n1+n2 observations. The special case of n2 = 0 is
possible and then the parametric (non-permutation) t-test can also be used.
This strategy keeps the α-level exactly, because the total variance 1
n1
∑n1
i=1 x
2
i
is invariant to the permutations.
In the two-sample case, the approach would permute the treatment allo-
cations of the observations. In order to preserve the observed total variance,
the permutations have to be done separately for the n1 observations of stage
1 and the n2 observations of stage 2, respectively.
If sample sizes are small, permutation tests suffer from the discreteness
of the resampling distribution and the associated loss of power. In this case,
rotation tests [4, 5] offer an attractive alternative. These replace the random
permutations of the sample units by random rotations. This renders the sup-
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port of the corresponding empirical distribution continuous and thus avoids
the discreteness problem of the permutation strategy. In order to facilitate
this, rotation tests require the assumption of a spherical null distribution.
This is the case in this context. Stage-1- and stage-2-data have to be rotated
separately even in the one-sample case in order to keep the fixed observed
stage-1-value of the total variance.
Permutation and rotation strategies emulate the true distribution of the
t test including sample size review. Hence, they will ”automatically” correct
any type I error inflation as outlined in the previous section, but will oth-
erwise have almost identical properties (e.g. with respect to power) as their
”parametric” counterpart. We did some simulations of the permutation and
rotation strategies under null and non-null scenarios. These, however, just
backed up the statements made here and are thus not reported.
3.2 Combinations of test statistics from the two stages
Methods that use a combination of test statistics from the two stages are
another alternative if one is looking for an exact test. For example, we might
use Fisher’s p-value combination −2 log(p1 · p2) [6] where pj = P (Tj > tj)
with Tj being the test statistic from stage-j-data only and tj its observation
from the concrete data at hand. As −2 log(p1 · p2) ∼ χ2(4) for independent
test statistics T1 and T2 under H0, the combination p-value test rejects H0 if
−2 log(p1 · p2) is larger than the (1 − α)-quantile from this distribution. In
this application, we use the true null distributions of the test statistics Tj to
determine the p-values. For example, in case of the one-sample-t-test these
are the t-distributions T1 ∼ t(n1 − 1) and T2 ∼ t(n2 − 1).
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The stage-2-sample size n2 is uniquely determined by
∑n1
i=1 x
2
i . Since T1
is a test statistic for which Theorem 2.5.8. of [3] holds under H0, the null
distribution of T1 is valid also conditionally on
∑n1
i=1 x
2
i . As a consequence,
T1 ∼ t(n1 − 1) and T2 ∼ t(n2 − 1) are stochastically independent under H0
for given
∑n1
i=1 x
2
i . Any combination of them can be used as the test statistic
for H0. Of course, one still has to find critical values of the null distribution
for the selected combination.
The statement about the conditional null distributions of the test statis-
tics given the total variance
∑n1
i=1 x
2
i allows us to go beyond Fisher’s p-value
combination and similar methods that are combining p-values using fixed
weights or calculate conditional error functions with an ”intended” stage-
2-sample size. The weights used to combine the two stages may also de-
pend on the observed stage-1-data. For example, if the variance were known
(and hence a z-test for H0 could be done), then the optimal (standardized)
weights for combining the z-statistics from the two stages would be
√
n1
n1+n2
and
√
n2
n1+n2
in the one-sample case. Hence, tcomb =
√
n1
n1+n2
t1 +
√
n2
n1+n2
t2
seems a promising candidate for a combination test statistic. The fact that
{Tj} , j = 1, 2 retain their t(nj − 1)-null distributions if we condition on
s21 =
∑n1
i=1 x
2
i means that critical values for this test can be obtained from
the distribution of the weighted sum of two stochastically independent t-
distributed random variables with (n1 − 1) and (n2 − 1) degrees of freedom,
respectively. It is obvious that this is very easy with numerical integration or
a simulation. Comparing tcomb with these critical values (that depend only
on n1 and n2) to decide about the rejection of H0 gives an exact level-α test.
To investigate the performance of the introduced suggestions, we did sev-
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eral simulations. The critical values for the one-sided one-sample test using
tcomb were obtained by simulating 1’000’000 values of two independent t-
distributions with n1 fixed and n2 as determined by the SSR method in [1].
We used the ”total variance” for SSR, not the ”adjusted variance” which
subtracts a constant based on the putative effect size. Nevertheless, the re-
estimated sample size of course depends on the ”assumed effect” which may
be different from the true, unknown effect size. In the simulations,we inves-
tigated various combinations of the true effect size µ and an assumed effect
size δ.
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Figure 1: Power of various test after sample size re-estimation
Null simulations verified the claimed type-I-error control for the various
adjustment methods described in this section and are thus not reported.
Figure 1 shows the results of 1’000’000 simulation runs for sample sizes of
n1 = 5 and n1 = 30, a true effect size of µ = 0.2 (the standardized true
effect size, such that the non-centrality parameter of a standard-t-test with
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n observations would be
√
nµ) and varying values of δ on the x-axis. The
unmodified t-test as suggested by [1] is always best. In comparison, the
weighted t-test combination tcomb suffers from a small power loss which seems
non-negligible only for very small stage-1-sample sizes below n1 = 10 (where
the type I error control of the ”reviewed” t-test might be a concern). For all
simulated scenarios with n1 = 30, the difference in power was always below
1%. In contrast, Fisher’s p-value combination typically loses 3 to 4 % of
power when t-test power is less than 95 % and up to 7% for some scenarios
(µ = 0.1, δ = 0.15 with power t-test 76.4%, power t-combination 76.3%,
power p-value combination 69.6%).
4 The distribution of Kieser and Friede’s t-
test statistic
To investigate the type I error of the t-test after a blinded sample size review,
Kieser and Friede [1] write the t-test statistic as a function of four components
D1, V1, D2 and V
∗
2 (see page 3575 of [1]) for which they derive respective
distributions. However, the distribution of V ∗2 given (D1, V1) mentioned there
is an approximation, not the exact distribution. Hence, the ”actual” type I
error rates in [1] are also approximate, possibly masking a minor type I error
level inflation.
The following uses the notation from [1]. It shows that the conditional
distribution of V ∗2 |(V1, D1) is not χ2(2n2).
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Without loss of generality it can be assumed that σ2 = 1. We have
V ∗2 = V2 +
n1n2
n1 + n2
((
X11 −X21
)2
+
(
X12 −X22
)2)
V2|(V1, D1) ∼ χ2(2n2 − 2) is obvious. It is also obvious that if we condition
on V1 only, and suppose that this determines sample size n2 uniquely, we
have
D∗i :=
√
n1n2
n1 + n2
(
X1i −X2i
) ∼ N(0, 1),
such that D∗1 and D
∗
2 are stochastically independent. Thus, in this case
D∗21 + D
∗2
2 ∼ χ2(2), so if n2 is a function of V1, but not D1, the claim
V ∗2 |V1 ∼ χ2(2n2) holds. This was noted by [7].
If we condition on both V1 and D1, V2 and (D
∗
1, D
∗
2) are still independent,
but D∗1 and D
∗
2 are no longer.
By applying a theorem on conditional normal distributions (see e.g. [8],
page 35) and some well-known results on matrix decompositions, it can be
shown that the true conditional distribution of V ∗2 is a mixture distribution:
V ∗2 |(V1, D1) =d χ22n2−1 + z22 ,
where ”=d ” denotes ”equal in distribution” and z
2
2 has the ”rescaled” non-
central χ2-distribution
z22 ∼
n1
n1 + n2
· χ2
(
1;
n2
n1
(
D1 −
√
n1
2
∆
)2)
.
The assumption V ∗2 |(V1, D1) ∼ χ2(2n2) will often very closely approxi-
mate this real distribution.
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5 Sample size reviews when testing for non-
inferiority
The preceding sections have dealt with the superiority test H0 : µ = 0.
While type I error violations in this context are extremely small, it was
noted by [13] that more serious violations arise in the case of non-inferiority
and equivalence testing and that these are persistent with larger sample sizes.
This section gives an intuitive explanation for this.
Assume that in the two-sample case, it is intended to test the non-
inferiority hypothesis H0 : µ1 − µ2 ≤ δ on data xijk ∼ N (µj, σ2) where
i = 1, 2 indexes stage, j = 1, 2 treatment group, k = 1, . . . , ni sample unit
and δ is a fixed non-inferiority margin. Sample size reassessment after stage
1 determines the stage-2-sample size via
n2 = 4 · (u1−α + u1−β)
2
(θ − δ)2 · σ˜
2 (2)
(where uα is the α-quantile of N(0, 1), β is the desired power of the ordinary
two-sample t-test and θ is the assumed true effect difference between the
treatments) as a function of the ”total variance”
σ˜2 =
1
2n1 − 1
2∑
j=1
n1∑
k=1
(x1jk − x¯1)2
with x¯1 =
∑
2
j=1
∑n1
k=1
x1jk
2n1
. This, however, does not correspond to a ”blinded”
sample size review of the corresponding superiority test. To see this, notice
that the described test can also be represented as a test of H0 : µ
∗
1 − µ2 ≤ 0
on the ”shifted” data
x∗ijk =

 xijk − δ if j = 1,xijk if j = 2, (3)
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A blinded sample size review of
(
x∗ijk
)
would also use (2), but with
σˆ2 =
1
2n1 − 1
2∑
j=1
n1∑
k=1
(
x∗1jk − x¯∗1
)2
instead of σ˜2. It is easy to see that
σ˜2 = σˆ2 − n1
2(2n1 − 1)δ
2 +
n1
2n1 − 1δ(x¯11 − x¯12).
This formula contains the quantity n1
2n1−1δ(x¯11− x¯12) which links the realized
difference in means x¯11− x¯12 with the true difference δ of means under H0. If,
for example, δ < 0, then n2 decreases with increasing realized values of x¯11−
x¯12. Relative to the blinded superiority sample size review, this means that
fewer additional sample elements are taken when stage-1-evidence is in favor
of the alternative and vice versa. Obviously, this must be associated with
an increase of type I error under H0. Conversely, the test gets conservative
when δ > 0. These tendencies were also noticed by [13] in simulations.
The ”blinded” non-inferiority test is thus equivalent to an ”unblinded”
superiority test and hence subject to type I error biases that afflict an un-
modified t-test applied after the sample size was modified using the observed
difference in means. To be sure, the user of the blinded non-inferiority re-
estimation does not get to see the realized value of x¯11− x¯12, but nevertheless
it has the described impact on the modified sample size n2.
6 Discussion
This paper investigates a number of situations with normally distributed ob-
servations where blinded sample size review according to Kieser and Friede
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does not control the type I error rate. In superiority testing, the correspond-
ing inflations are extremely small and occur with sample sizes that will rarely
be of practical relevance. The method can thus safely be used in practice.
As an alternative for which type I error control can be proved, it is
also possible to combine the t-test statistics of the two stages directly us-
ing data-dependent weights. Regarding the outcome in practical applica-
tions, these two methods are virtually indistinguishable. In contrast, p-value-
combination and related methods suffer from some power loss due to the fact
that they have to work with a predetermined ”intended” stage-2-sample size
and lose power if one deviates from this intention in the sample size review.
Non-inferiority testing is subject to much more severe type I error vio-
lations. This is due to its equivalence with unblinded superiority testing.
As a consequence, blinded SSR is not an acceptable method in confirmatory
clinical trials.
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7 Technical Appendix
This appendix shows that V ∗2 |(V1, D1) has the distribution given in section
4. By applying the usual theorems on conditional normal distributions (see
e.g. [8], page 35), we obtain the bivariate distribution
D∗ :=
(
D∗1
D∗2
)
|(V1, D1) =
(
D∗1
D∗2
)
|(n2, D1) ∼ (4)
N2

(
√
n2
2(n1+n2)
(
D1 −
√
n1
2
∆
)
−
√
n2
2(n1+n2)
(
D1 −
√
n1
2
∆
)
)
;

 2n1+n22(n1+n2) n22(n1+n2)
n2
2(n1+n2)
2n1+n2
2(n1+n2)




To derive the distribution of D∗
′
D∗ = D∗21 +D
∗2
2 , we can make use of the
following well-known general result:
Suppose x ∼ Np(µ,V) and let V 12 be a root of V (i.e. a matrix that
fulfills V
1
2V
1
2 = V). Then x =d V
1
2y where y ∼ Np(V− 12µ, Ip).
Furthermore assume that A is a positive semidefinite symmetric p × p-
matrix. Then
x′Ax =d y
′V
1
2AV
1
2y. (5)
V
1
2AV
1
2 can also be written as an eigenvalue decomposition C′ΛC, where
Λ = (λi)i=1,...,p is the diagonal matrix of eigenvalues and C is the matrix of
the corresponding eigenvectors. Inserting this into (5), we obtain
x′Ax =d
∑
i
λiz
2
i
with z = (z1, . . . , zp)
′ ∼ N
(
C′V−
1
2µ, Ip
)
.
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Using this general result in the particular case by setting µ and V to
the mean and covariance matrix in (4) and A = I2, it is easy to see that
V has eigenvalues 1 and n1
n1+n2
and eigenvectors 1√
2
· (1, 1)′ and 1√
2
· (1,−1)′.
Consequently, conditional on (V1, D1), we obtain:
D∗21 +D
∗2
2 =d z
2
1 + z
2
2
where z1 ∼ N(0, 1) and z2 ∼ N(
√
n2
n1+n2
· (D1 −√n12 ∆) , n1n1+n2 ). Hence,
V ∗2 |(V1, D1) =d χ22n2−1 + z22 , where z22 has the ”rescaled” non-central χ2-
distribution
z22 ∼
n1
n1 + n2
· χ2
(
1;
n2
n1
(
D1 −
√
n1
2
∆
)2)
.
We note in passing that if D∗
′
D∗ were χ2(2)-distributed, it would have
E(D∗
′
D∗) = 2. The true conditional expected value given (V1, D1) can be
obtained from
E(D∗
′
D∗) = tr(E(D∗D∗
′
)) = tr(ΣD∗ + µD∗µ
′
D∗
) =
1 +
n1
n1 + n2
+
n2
n1 + n2
(
D1 −
√
n1
2
∆
)2
.
Of course, this is not equal to 2 in general. However, E(
(
D1 −
√
n1
2
∆
)2
) =
1 holds, since D1 ∼ N
(√
n1
2
∆, 1
)
. If we then ignore that n2 is a random
variable as well, we obtain the approximate unconditional expected value(
1 + n1
n1+n2
+ n2
n1+n2
)
= 2.
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